http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
박정랑 ( Jeong Lang Park ),정상혁 ( Sang Hyuk Jung ),채유미 ( Yoo Mi Chae ) 한국보건행정학회 2007 보건행정학회지 Vol.17 No.4
This studr aimed to analyze the factors that influence the job satisfaction of nurses involved in medical insurance reviews, The study involved a self-administered questionnaire survey which was conducted with to 297 nurses who were in charge of medical insurance reviews between April 10 and April 28, 2006. The average job satisfaction of the subjects was 3.04, The sub-items of job satisfaction were noted to be high for ``professional status``(3,79) and low for wage (2.46), The job satisfaction of subjects showed statistically significant differences with regard to education, career, and volume of service(p<0.05), The average job stress of subjects was 2.57. The sub-items of job stress included problems pertaining to human relationships problem(2.84), conflicts with doctors at work (2.79), and the burden of excessive workloads(2.79), in that order, Multiple regression analysis demonstrated that job satisfaction was significantly low when the job stress was higher, It also showed that the job satisfaction was significantly high as there was more frequency of judgements and higher education. These results suggest that the job stress of nurses involved in medical insurance reviews has a profound impact on their job satisfaction. Therefore, the efforts should be made to reduce their job stress. It may also be beneficial to reinforce the training with the doctors and nurses in order to improve their communication skills, Disseminating more information about insurance standards may also be considered.
진행성 비소세포 폐암 환자에서 Gemcitabine, Cisplatin 3주 주기 복합화학요법
김석현 ( Kim Seog Hyeon ),이경원 ( Lee Gyeong Won ),윤지향 ( Yun Ji Hyang ),심기식 ( Sim Gi Sig ),이영미 ( Lee Yeong Mi ),강도연 ( Kang Do Yeon ),박정랑 ( Park Jeong Lang ),정정화 ( Jeong Jeong Hwa ),신민기 ( Sin Min Gi ),정이영 ( 대한내과학회 2004 대한내과학회지 Vol.66 No.1
진행성 비소세포 폐암 환자에서 gemcitabine 1,200 ㎎/㎡을 1일째, 8일째 투여하고, cisplatin 80 ㎎/㎡을 1일째 투여하는 3주 간격의 복합 항암 화학요법은 효과적이고, 독성 또한 감내할만 하였다. 향후 국내에서 보다 많은 수의 환자들을 대상으로 3주 간격과 4주 간격의 비교 및 용량 강도에 따른 반응률 및 생존기간이 비교 가능한 대규모의 전향적 무작위 다기관 임상 3상 연구가 이루어져야 하겠다. Background : The combination chemotherapy of gemcitabine and cisplatin has been proven effective in the treatment of advanced non-small cell lung cancer (NSCLC). However, the optimal schedule for administration of the two drugs has not yet been determined